Navigation Links
Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug
Date:6/22/2009

Technology Intended to Improve Outcome of Intrauterine Insemination and In Vitro Fertilization Procedures

LA JOLLA, Calif., June 22 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced today that it has entered into an agreement with Clinical Trials International, LLC, (CTI), regarding a license to develop and market Cordex's drug candidate, ATPotent(TM).

ATPotent(TM) is a novel ATP-based drug candidate designed for in vitro (outside of the human body) treatment of sperm in conjunction with intrauterine insemination (IUI) and in vitro fertilization (IVF) procedures. ATPotent(TM) is based on Cordex's proprietary technologies related to the use of adenosine 5'-triphosphate (ATP) for improving human and animal sperm motility and fertilization capacity.

According to the agreement, CTI has obtained exclusive rights for the clinical development and marketing of ATPotent(TM) in the European Union (EU) as well as Russia and Ukraine. CTI intends to initiate with Cordex's scientific support a proof-of-concept clinical trial in Italy later this year, the end-point of which is expected to be increased pregnancy rate in IUI procedures prescribed for couples with male infertility due to asthenozoospermia (i.e., low or lack of sperm motility). Cordex will have access to the clinical data to be obtained in this study to support the development of ATPotent(TM) in the rest of the world.

Male factor infertility is implicated in about half of the six million infertile couples in the United States. Lack of, or low sperm motility or movement, is a common cause of human male infertility. It has been reported in the medical literature that the prevalence of asthenozoospermia in infertile men is approximately 82 percent. Currently, there is no FDA-approved drug that enhances sperm motility.

Cordex has sponsored studies at the University of Pennsylvan
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures
2. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
3. Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
4. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
5. Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC
6. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
7. Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan
8. MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
9. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
10. Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
11. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Report ... for leading ophthalmic drug companies  What does ... pharma ophthalmic industry ? Visiongain,s brand new report shows ... and prospects there. Our 242-page report provides ... areas in the industry and the future market prospects. ...
(Date:3/27/2015)... 27, 2015 As of February, InControl ... devices for women. "Shipping thousands of ... part is the hundreds of letters, emails and ... have been positively impacted by our technology," said ... InControl recently released Apex, an over-the-counter solution ...
(Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... , SCOTTSDALE, Ariz., Oct. 14 When it comes ... it is easy to point a finger at a ... regulations. But new data from the 2009 Leadership Skills ... ( http://www.gottochange.com ), indicates that the root ...
... INDIANAPOLIS, Oct. 14 Eli Lilly and Company (NYSE: ... Tippecanoe Laboratories manufacturing facility to Evonik Industries AG, one ... located in Lafayette, Indiana, will remain in operation with ... and specialty chemical and animal health products. In connection ...
Cached Medicine Technology:Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 2Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 2Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 4
(Date:3/27/2015)... Mo (PRWEB) March 27, 2015 ... for patients undergoing percutaneous coronary intervention (PCI), resulting ... have observed a “risk-treatment paradox,” in which the ... from treatment are treated less often with bleeding ... at Saint Luke’s Mid America Heart Institute asked ...
(Date:3/27/2015)... La Mirada, CA (PRWEB) March 27, 2015 ... medicine physician, Stanley G. Katz, M.D., is now treating ... Southern California, including Anaheim , Long Beach, and ... and treatment of acute knee and hip joint disorders ... Dr. Stanley Katz is passionate in returning his patients ...
(Date:3/27/2015)... Ticket Down is a reputable source for authentic tickets ... a phenomenal and highly successful live tour last year, the cast ... tour again in 2015 and they will be visiting 8 cities ... in New York City at the cozy Beacon Theatre and will ... 10th. , Fans of the hit show can look forward to ...
(Date:3/27/2015)... March 27, 2015 While deep learning was ... GPU technology conference (GTC) , the CEO of one start-up ... push the human lifespan well beyond the generally-agreed ceiling of ... company , is one of 12 companies recognized as the ... startups in the GTC Emerging Companies Summit have ...
(Date:3/27/2015)... Vancouver, BC (PRWEB) March 27, 2015 ... Research ( http://www.idataresearch.com ), the plate and screw market ... sales in the generic plate and screw segment. Price ... device market. Despite representing almost 50% of the total ... projected to decrease the total market value, year after ...
Breaking Medicine News(10 mins):Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 3Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 3
... But sites devoted to complementary or alternative medicine may ... 11 (HealthDay News) -- Just 5 percent of Web ... pages focused on complementary or alternative medicine are 15 ... other false information, a new study says. , Moreover, ...
... DC When the public considers competing arguments about a ... agree with the expert whose values are closest to their ... will hold true for nanotechnology, a key study has found. ... today by the Project on Emerging Nanotechnologies (PEN). The study ...
... ... - $352 Average Patient Charge (APC) ... - $13.9 Million EBITDA From Continuing Operations ... 2008 Guidance, SCOTTSDALE, Ariz., Feb. 11 Rural/Metro,Corporation (Nasdaq: RURL ), a leading provider ...
... National Insurers Bring Programs to the State, While ... According to a New Report from HealthLeaders-InterStudy, ... of managed care market intelligence, reports that pay-for-,performance ... According to the,latest Arizona Health Plan Analysis, the ...
... recent years, increasing attention,has been paid to the ... In some instances, proponents of LBA made,overly-optimistic claims ... predictor in,the underwriting process. Milliman expert Jonathan Shreve, ... effective use of Lifestyle-Based,Analytics as an advance in ...
... SAN JUAN, Puerto Rico, Feb. 11 Triple-S,Management Corporation ... in,Puerto Rico, today announced record consolidated operating income of ... $2.15 for the year ended,December 31, 2007 (including $0.07 ... Company,s strong market position and medical cost,management., ...
Cached Medicine News:Health News:Most Breast Cancer Web Pages Contain Reliable Information 2Health News:Nanotechnology's future depends on who the public trusts 2Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 2Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 3Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 4Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 5Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 6Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 7Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 8Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 9Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 10Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 11Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 12Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 13Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 14Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 15Health News:Pay-For-Performance Not Getting a Red-Carpet Reception in Arizona 2Health News:Milliman Expert Addresses Practical Applications of Lifestyle-Based Analytics in Risk Selection 2Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 2Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 3Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 4Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 5Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 6Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 7Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 8Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 9Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 10Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 11Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 12Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 13
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: